Microarrays in pharmacogenomics--advances and future promise.
暂无分享,去创建一个
M. Chicurel | Marina E Chicurel | Dennise D Dalma-Weiszhausz | D. Dalma-Weiszhausz | D. Dalma‐Weiszhausz
[1] A Chakravarti,et al. High-throughput variation detection and genotyping using microarrays. , 2001, Genome research.
[2] Mary V. Relling,et al. Pharmacogenetics and cancer therapy , 2001, Nature Reviews Cancer.
[3] W. Evans,et al. Pharmacogenomics: unlocking the human genome for better drug therapy. , 2001, Annual review of pharmacology and toxicology.
[4] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Idle,et al. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.
[6] Integrating genomics technologies in health care: practice and policy challenges and opportunities. , 2002, Physiological genomics.
[7] M. Kruhøffer,et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. , 2001, Cancer research.
[8] S. P. Fodor,et al. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.
[9] T. Gingeras,et al. Analysis of Drug Pharmacology towards Predicting Drug Behavior by Expression Profiling Using High‐Density Oligonucleotide Arrays , 2000, Annals of the New York Academy of Sciences.
[10] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] Emanuel Petricoin,et al. Molecular profiling of human cancer , 2000, Nature Reviews Genetics.
[12] T. Stamey,et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.
[13] D. Gerhold,et al. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. , 2001, Physiological genomics.
[14] S. M. Kim,et al. Cystic fibrosis mutation detection by hybridization to light‐generated DNA probe arrays , 1996, Human mutation.
[15] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[16] T. Golub,et al. DNA microarrays in clinical oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[18] F. Vogel. Moderne Probleme der Humangenetik , 1959 .
[19] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.
[20] A Guiseppi-Elie,et al. New developments in microarray technology. , 2001, Current opinion in biotechnology.
[21] K. Weiss,et al. How many diseases does it take to map a gene with SNPs? , 2000, Nature Genetics.
[22] C. Sawyers,et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.
[23] T. Rebbeck,et al. More about: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. , 2000, Journal of the National Cancer Institute.
[24] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[25] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. P. Fodor,et al. Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.
[27] J. Johnson,et al. Pharmacogenomics: the inherited basis for interindividual differences in drug response. , 2001, Annual review of genomics and human genetics.
[28] R. Todd,et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis , 2001, Oncogene.
[29] L. Staudt,et al. It's ALL in the diagnosis. , 2002, Cancer cell.
[30] Jennifer Couzin,et al. New Mapping Project Splits the Community , 2002, Science.
[31] C. Sawyers,et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.
[32] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[33] Christian A. Rees,et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Murphy,et al. Single nucleotide polymorphisms and their characterization with oligonucleotide microarrays. , 2002, Psychiatric genetics.
[35] S. Ethier,et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.
[36] B. Pollock,et al. CYP2D6 Genotyping with Oligonucleotide Microarrays and Nortriptyline Concentrations in Geriatric Depression , 2001, Neuropsychopharmacology.
[37] John N. Weinstein,et al. Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis-Driven Research , 2002, Disease markers.
[38] M. Ratain,et al. Update on pharmacogenetics in cancer chemotherapy. , 2002, European journal of cancer.
[39] T. Gingeras,et al. Microarrays and genetic epidemiology: A multipurpose tool for a multifaceted field , 2002, Genetic epidemiology.
[40] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[41] M. Relling,et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites , 1999, The Lancet.
[42] S. P. Fodor,et al. Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.
[43] Tatyana Chernova,et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease , 2002, Nature.
[44] Seth Sadis,et al. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. Farnham,et al. Expression profiling and identification of novel genes in hepatocellular carcinomas , 2001, Oncogene.
[46] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[47] U. Alon,et al. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.
[48] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] P. Kwok,et al. Methods for genotyping single nucleotide polymorphisms. , 2003, Annual review of genomics and human genetics.
[50] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[51] Wei Li,et al. Effects of Early Angiotensin-Converting Enzyme Inhibition on Cardiac Gene Expression After Acute Myocardial Infarction , 2001, Circulation.
[52] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] U. Scherf,et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling , 2001, Cancer.
[54] M Heath-Chiozzi,et al. Clinical application of pharmacogenetics. , 2001, Trends in molecular medicine.
[55] P. Carson,et al. Enzymatic deficiency in primaquine-sensitive erythrocytes. , 1956, Science.
[56] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[57] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[58] T. Golub,et al. Genome-wide views of cancer. , 2001, The New England journal of medicine.
[59] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[60] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[61] J. Downing,et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.
[62] E. Winzeler,et al. Genomics, gene expression and DNA arrays , 2000, Nature.
[63] J. Winer,et al. Synergistic Induction of Tumor Antigens by Wnt-1 Signaling and Retinoic Acid Revealed by Gene Expression Profiling* , 2002, The Journal of Biological Chemistry.
[64] J. Hirschhorn,et al. A comprehensive review of genetic association studies , 2002, Genetics in Medicine.
[65] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] S. P. Fodor,et al. High density synthetic oligonucleotide arrays , 1999, Nature Genetics.
[67] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[68] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[69] D. Nebert,et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism , 1988, Nature.
[70] Pui-Yan Kwok,et al. Genetic Association by Whole-Genome Analysis? , 2001, Science.